
    
      In this study, eligible patients with type 2 diabetes will be randomized to either
      intermittent insulin therapy or not, on a background of metformin, after first undergoing a
      short course of intensive insulin therapy. The hypothesis under study is whether intermittent
      insulin therapy can preserve beta-cell function.
    
  